Trial Profile
High-dose versus standard-dose valsartan in patients with mild-to-moderate hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Dec 2011
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms ValTop
- Sponsors Novartis
- 05 Nov 2010 New trial record.